401 related articles for article (PubMed ID: 21709263)
1. Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cells.
Liu YC; Yen HY; Chen CY; Chen CH; Cheng PF; Juan YH; Chen CH; Khoo KH; Yu CJ; Yang PC; Hsu TL; Wong CH
Proc Natl Acad Sci U S A; 2011 Jul; 108(28):11332-7. PubMed ID: 21709263
[TBL] [Abstract][Full Text] [Related]
2. Identification of potential glycan cancer markers with sialic acid attached to sialic acid and up-regulated fucosylated galactose structures in epidermal growth factor receptor secreted from A431 cell line.
Wu SL; Taylor AD; Lu Q; Hanash SM; Im H; Snyder M; Hancock WS
Mol Cell Proteomics; 2013 May; 12(5):1239-49. PubMed ID: 23371026
[TBL] [Abstract][Full Text] [Related]
3. Core fucosylation regulates epidermal growth factor receptor-mediated intracellular signaling.
Wang X; Gu J; Ihara H; Miyoshi E; Honke K; Taniguchi N
J Biol Chem; 2006 Feb; 281(5):2572-7. PubMed ID: 16316986
[TBL] [Abstract][Full Text] [Related]
4. N-Glycan fucosylation of epidermal growth factor receptor modulates receptor activity and sensitivity to epidermal growth factor receptor tyrosine kinase inhibitor.
Matsumoto K; Yokote H; Arao T; Maegawa M; Tanaka K; Fujita Y; Shimizu C; Hanafusa T; Fujiwara Y; Nishio K
Cancer Sci; 2008 Aug; 99(8):1611-7. PubMed ID: 18754874
[TBL] [Abstract][Full Text] [Related]
5. β-Catenin/CBP inhibition alters epidermal growth factor receptor fucosylation status in oral squamous cell carcinoma.
Chandler KB; Alamoud KA; Stahl VL; Nguyen BC; Kartha VK; Bais MV; Nomoto K; Owa T; Monti S; Kukuruzinska MA; Costello CE
Mol Omics; 2020 Jun; 16(3):195-209. PubMed ID: 32203567
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of EGFR and RTK signaling in the electrotaxis of lung adenocarcinoma cells under direct-current electric field stimulation.
Tsai HF; Huang CW; Chang HF; Chen JJ; Lee CH; Cheng JY
PLoS One; 2013; 8(8):e73418. PubMed ID: 23951353
[TBL] [Abstract][Full Text] [Related]
7. A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.
Fichter CD; Przypadlo CM; Buck A; Herbener N; Riedel B; Schäfer L; Nakagawa H; Walch A; Reinheckel T; Werner M; Lassmann S
J Pathol; 2017 Dec; 243(4):481-495. PubMed ID: 28940194
[TBL] [Abstract][Full Text] [Related]
8. Glycosylation-induced conformational modification positively regulates receptor-receptor association: a study with an aberrant epidermal growth factor receptor (EGFRvIII/DeltaEGFR) expressed in cancer cells.
Fernandes H; Cohen S; Bishayee S
J Biol Chem; 2001 Feb; 276(7):5375-83. PubMed ID: 11087732
[TBL] [Abstract][Full Text] [Related]
9. The extracellular domain of the epidermal growth factor receptor. Studies on the affinity and stoichiometry of binding, receptor dimerization and a binding-domain mutant.
Brown PM; Debanne MT; Grothe S; Bergsma D; Caron M; Kay C; O'Connor-McCourt MD
Eur J Biochem; 1994 Oct; 225(1):223-33. PubMed ID: 7925442
[TBL] [Abstract][Full Text] [Related]
10. Effect of sialylation on EGFR phosphorylation and resistance to tyrosine kinase inhibition.
Yen HY; Liu YC; Chen NY; Tsai CF; Wang YT; Chen YJ; Hsu TL; Yang PC; Wong CH
Proc Natl Acad Sci U S A; 2015 Jun; 112(22):6955-60. PubMed ID: 25971727
[TBL] [Abstract][Full Text] [Related]
11. High levels of EGFR prevent sulforaphane-induced reactive oxygen species-mediated apoptosis in non-small-cell lung cancer cells.
Wang TH; Chen CC; Huang KY; Shih YM; Chen CY
Phytomedicine; 2019 Nov; 64():152926. PubMed ID: 31454652
[TBL] [Abstract][Full Text] [Related]
12. Mammalian α-1,6-Fucosyltransferase (FUT8) Is the Sole Enzyme Responsible for the N-Acetylglucosaminyltransferase I-independent Core Fucosylation of High-mannose N-Glycans.
Yang Q; Wang LX
J Biol Chem; 2016 May; 291(21):11064-71. PubMed ID: 27008861
[TBL] [Abstract][Full Text] [Related]
13. FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation.
Tu CF; Wu MY; Lin YC; Kannagi R; Yang RB
Breast Cancer Res; 2017 Oct; 19(1):111. PubMed ID: 28982386
[TBL] [Abstract][Full Text] [Related]
14. Loss of core fucosylation in both ST6GAL1 and its substrate enhances glycoprotein sialylation in mice.
Huang G; Li Z; Li Y; Liu G; Sun S; Gu J; Kameyama A; Li W; Dong W
Biochem J; 2020 Mar; 477(6):1179-1201. PubMed ID: 32141499
[TBL] [Abstract][Full Text] [Related]
15. Posttranslational modification of E-cadherin by core fucosylation regulates Src activation and induces epithelial-mesenchymal transition-like process in lung cancer cells.
Shao K; Chen ZY; Gautam S; Deng NH; Zhou Y; Wu XZ
Glycobiology; 2016 Feb; 26(2):142-54. PubMed ID: 26443198
[TBL] [Abstract][Full Text] [Related]
16. Sialylation of epidermal growth factor receptor regulates receptor activity and chemosensitivity to gefitinib in colon cancer cells.
Park JJ; Yi JY; Jin YB; Lee YJ; Lee JS; Lee YS; Ko YG; Lee M
Biochem Pharmacol; 2012 Apr; 83(7):849-57. PubMed ID: 22266356
[TBL] [Abstract][Full Text] [Related]
17. TRAF4 binds to the juxtamembrane region of EGFR directly and promotes kinase activation.
Cai G; Zhu L; Chen X; Sun K; Liu C; Sen GC; Stark GR; Qin J; Li X
Proc Natl Acad Sci U S A; 2018 Nov; 115(45):11531-11536. PubMed ID: 30352854
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive N-glycan profiles of hepatocellular carcinoma reveal association of fucosylation with tumor progression and regulation of FUT8 by microRNAs.
Cheng L; Gao S; Song X; Dong W; Zhou H; Zhao L; Jia L
Oncotarget; 2016 Sep; 7(38):61199-61214. PubMed ID: 27533464
[TBL] [Abstract][Full Text] [Related]
19. In-depth N-glycome profiling of paired colorectal cancer and non-tumorigenic tissues reveals cancer-, stage- and EGFR-specific protein N-glycosylation.
Sethi MK; Kim H; Park CK; Baker MS; Paik YK; Packer NH; Hancock WS; Fanayan S; Thaysen-Andersen M
Glycobiology; 2015 Oct; 25(10):1064-78. PubMed ID: 26085185
[TBL] [Abstract][Full Text] [Related]
20. Biosynthesis of sialylated and fucosylated selectin ligands of HL-60 cells in vitro. Midchain alpha3-fucose units inhibit terminal alpha6-sialylation but not alpha3-sialylation of polylactosamines.
Natunen J; Parmanne P; Helin J; Aitio O; Majuri ML; Niemelä R; Renkonen R; Renkonen O
FEBS Lett; 1999 Jun; 452(3):272-6. PubMed ID: 10386605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
